Question 1

What is the catalog number for Human ANO4 Pre-designed siRNA Set B?

Accepted Answer

The catalog number for Human ANO4 Pre-designed siRNA Set B is SI000761B.

Question 2

What sizes are available for Human ANO4 Pre-designed siRNA Set B?

Accepted Answer

Human ANO4 Pre-designed siRNA Set B is available in the following size(s): 1 Each.

Question 3

Is Human ANO4 Pre-designed siRNA Set B in stock?

Accepted Answer

Human ANO4 Pre-designed siRNA Set B is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What expression system was used for this recombinant protein?

Accepted Answer

The expression system, such as E. coli, HEK293, or insect cells, is listed on the datasheet under production details, which can affect post-translational modifications relevant to your application.

Question 5

Can I return this product if I ordered the wrong one?

Accepted Answer

As a consumer, you have a 14-day right of withdrawal from receipt under EU consumer protection law, submitted via our withdrawal/cancellation request form. Note this applies to unused, undamaged products, and doesn’t override the expiry/storage conditions on performance-based claims.

Question 6

Is this product tested for endotoxin levels?

Accepted Answer

Endotoxin testing status is noted on the datasheet where applicable, particularly for recombinant proteins intended for cell-based or functional assays. If this isn’t listed and you need confirmation, contact support with the catalogue number.

Human ANO4 Pre-designed siRNA Set B

Product Specifications

Short Description

Gene Name

Gene Aliases

Gene ID

Purification Method

Shipping Conditions

Storage Conditions

Shelf Life

Species

Frequently Asked Questions

Explore Other Products

Human PHGDH activation kit by CRISPRa

CD63 (Late Endosomes Marker) (LAMP3/2881), CF488A conjugate, 0.1mg/mL

Thymidylate Synthase (TS106 + TMS715), CF740 conjugate, 0.1mg/mL

Human IFNGR2 activation kit by CRISPRa

N-Carbobenzyloxy-3-phenylthio-L-alanine

MHC II (HLA-DRA) (19-26.1), 0.2mg/mL